CoChat

Are tumor-infiltrating lymphocytes protagonists or background actors in patient selection for cancer immunotherapy?

Zito Marino, Federica, Ascierto, Paolo Antonio, Rossi, Giulio, Staibano, Stefania, Montella, Marco, Russo, Daniela, Alfano, Roberto, Morabito, Alessandro, Botti, Gerardo, Franco, Renato · 2017 · Expert Opinion on Biological Therapy
Cited by 73

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Abstract

INTRODUCTION: Tumor-infiltrating lymphocytes (TILs) are frequently observed in several tumors, reflecting the dynamic process of '"cancer immunoediting"'. Prognostic and predictive values of TILs have been demonstrated in different cancers, proving their pivotal role in clinical outcome. In recent years, new therapies targeting immune checkpoint inhibitors, especially CTLA-4 and PD-1/PDL-1 pathways, have been introduced into clinical practice. In this context, TILs may even have a possible utility as a predictive biomarker for immunotherapy response. Areas covered: In this review, the authors summarize the most relevant knowledge related to TILs. This includes their prognostic and predictive significance in various types of tumour and the recent findings about their potential role in the cancer immunotherapy. Expert opinion: TILs evaluation could lead to a predictive biomarker for immunotherapy effectiveness in several cancer types. Furthermore, typing of TILs subpopulation could have clinical relevance in patient selection for treatment with immune checkpoint inhibitors. However further studies are still needed.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1080/14712598.2017.1309387

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Cited by

See all 73

Metadata

Authors
Zito Marino, F., Ascierto, P. A., Rossi, G., Staibano, S., Montella, M., Russo, D., Alfano, R., Morabito, A., Botti, G., & Franco, R.
Venue
Expert Opinion on Biological Therapy
Published
2017-03-28
Volume
17
Issue
6
Pages
735-746
ISSN
  • 1471-2598 (ISSN-L)
  • 1744-7682
OpenAlex
W2598255954
Cited by
73
References
9
FWCI
2.69
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Are tumor-infiltrating lymphocytes protagonists or background actors in patient selection for cancer immunotherapy? https://app.cochat.ai/papers/10.1080/14712598.2017.1309387
The paper
Zito Marino, F., Ascierto, P. A., Rossi, G., Staibano, S., Montella, M., Russo, D., Alfano, R., Morabito, A., Botti, G., & Franco, R. (2017). Are tumor-infiltrating lymphocytes protagonists or background actors in patient selection for cancer immunotherapy? Expert Opinion on Biological Therapy. https://doi.org/10.1080/14712598.2017.1309387

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.